Referanslar

1. WHO Cancer. Available online: (accessed on 12 February 2021). [Link]
2. Parkin DM, Boyd L, Walker LC. The fraction of cancer at- tributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(2):77-81. [Crossref]  [PubMed]
3. Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S, Hoffmann G, et al. Dietary Sup- plements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Anal- ysis of Primary Prevention Trials. Advances in nutrition (Bethesda, Md). 2017;8(1):27-39. [Crossref]  [PubMed]
4. Yildiz A, Kaya Y, Tanriverdi O. Effect of the Interaction Between Selenium and Zinc on DNA Repair in Associ- ation With Cancer Prevention. Journal of cancer preven- tion. 2019;24(3):146-54. [Crossref]  [PubMed]
5. Salganik RI. The benefits and hazards of antioxidants: con- trolling apoptosis and other protective mechanisms in cancer patients and the human population. Journal of the American College of Nutrition. 2001;20(5):464-472. [Crossref]  [PubMed]
6. Sihvo EI, Salminen JT, Rantanen TK, Rämö OJ, Ahotupa M, Färkkilä M, et al. Oxidative stress has a role in ma- lignant transformation in Barrett's oesophagus. Int J Can- cer. 2002;102(6):551-55. [Crossref]  [PubMed]
7. Fagbohun OF, Gillies CR, Murphy KPJ, Rupasinghe HPV. Role of Antioxidant Vitamins and Other Micronutrients on Regulations of Specific Genes and Signaling Pathways in the Prevention and Treatment of Cancer. International jour- nal of molecular sciences. 2023;24(7).6092. [Crossref]  [PubMed]
8. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. An- tioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet. 2004;364(9441):1219-28. [Crossref]  [PubMed]
9. Godswill AG, Somtochukwu IV, Ikechukwu AO, Kate EC. Health benefits of micronutrients (vitamins and minerals) and their associated deficiency diseases: A systematic re- view. International Journal of Food Sciences.2020;3(1):1-32. [Crossref]
10. Marques O, da Silva BM, Porto G, Lopes C. Iron homeosta- sis in breast cancer. Cancer Lett. 2014 May 28;347(1):1-14. [Crossref]  [PubMed]
11. Oliai Araghi S, Kiefte-de Jong JC, van Dijk SC, Swart KMA, van Laarhoven HW, van Schoor NM, et al. Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial. Cancer epidemiology, biomarkers & prevention : A publi- cation of the American Association for Cancer Research, cosponsored by the American Society of Preventive On- cology. 2019;28(2):275-82. [Crossref]  [PubMed]
12. Kim H, Lee J, Woo HD, Kim DW, Oh JH, Chang HJ, et al. Dietary mercury intake and colorectal cancer risk: A case-control study. Clinical nutrition (Edinburgh, Scot- land). 2020;39(7):2106-13. [Crossref]  [PubMed]
13. Irimie AI, Braicu C, Pasca S, Magdo L, Gulei D, Cojoc- neanu R, et al. Role of Key Micronutrients from Nutrigen- etic and Nutrigenomic Perspectives in Cancer Prevention. Medicina (Kaunas, Lithuania). 2019;55(6).283. [Crossref]  [PubMed]
14. Turkiewicz J, Garcia M, Li Z, Surampudi V. Micronutrient deficiencies in patients with gastrointestinal cancer: To treat or not to treat. Nutrition in clinical practice : official publi- cation of the American Society for Parenteral and Enteral Nutrition. 2023;38(4):749-60. [Crossref]  [PubMed]
15. Murillo AG, Fernandez ML. Potential of dietary non-pro- vitamin A carotenoids in the prevention and treatment of diabetic microvascular complications. Advances in Nu- trition. 2016;7(1):14-24. [Crossref]  [PubMed]
16. Zhang Y, Yang J, Na X, Zhao A. Association between β-carotene supplementation and risk of cancer: a me- ta-analysis of randomized controlled trials. Nutrition re- views. 2023;81(9):1118-30. [Crossref]  [PubMed]
17. Anonymous. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The New England journal of medicine. 1994;330(15):1029-35. [Crossref]  [PubMed]
18. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. The New England journal of medicine. 1996;334(18):1150-5. [Crossref]  [PubMed]
19. Chen H, Tucker KL, Graubard BI, Heineman EF, Markin RS, Potischman NA, et al. Nutrient intakes and adenocar- cinoma of the esophagus and distal stomach. Nutrition and cancer. 2002;42(1):33-40. [Crossref]  [PubMed]
20. De Stefani E, Boffetta P, Brennan P, Deneo-Pellegrini H, Carzoglio JC, Ronco A, et al. Dietary carotenoids and risk of gastric cancer: a case-control study in Uruguay. European journal of cancer prevention : The 0fficial Jour- nal of the European Cancer Prevention Organisation (ECP). 2000;9(5):329-34. [Crossref]  [PubMed]
21. Correa P, Piazuelo MB, Camargo MC. The future of gas- tric cancer prevention. Gastric cancer : Official journal of the International Gastric Cancer Association and the Japa- nese Gastric Cancer Association. 2004;7(1):9-16. [Crossref]  [PubMed]
22. Larsson SC, Bergkvist L, Näslund I, Rutegård J, Wolk A. Vitamin A, retinol, and carotenoids and the risk of gastric cancer: a prospective cohort study. The American journal of clinical nutrition. 2007;85(2):497-503. [Crossref]  [PubMed]
23. Zhang W, Shu XO, Li H, Yang G, Cai H, Ji BT, et al. Vi- tamin intake and liver cancer risk: a report from two co- hort studies in China. Journal of the National Cancer Insti- tute. 2012;104(15):1173-81. [Crossref]  [PubMed]
24. Lai GY, Weinstein SJ, Taylor PR, McGlynn KA, Virtamo J, Gail MH, et al. Effects of -tocopherol and -carotene supplementation on liver cancer incidence and chron- ic liver disease mortality in the ATBC study. Br J Can- cer. 2014;111(12):2220-3. [Crossref]  [PubMed]
25. Thorne J, Campbell MJ. The vitamin D receptor in cancer. The Proceedings of the Nutrition Society. 2008;67(2):115-27. [Crossref]  [PubMed]
26. Okayasu I, Hana K, Nemoto N, Yoshida T, Saegusa M, Yokota-Nakatsuma A, et al. Vitamin A Inhibits Develop- ment of Dextran Sulfate Sodium-Induced Colitis and Co- lon Cancer in a Mouse Model. BioMed research interna- tional. 2016;2016:4874809. [Crossref]  [PubMed]
27. Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B Vitamins and Their Role in Immune Regulation and Can- cer. Nutrients. 2020;12(11). [Crossref]  [PubMed]
28. Yuan S, Carter P, Vithayathil M, Kar S, Mason AM, Bur- gess S, et al. Genetically predicted circulating B vita- mins in relation to digestive system cancers. Br J Cancer. 2021;124(12):1997-2003. [Crossref]  [PubMed]
29. Fedde KN, Whyte MP. Alkaline phosphatase (tissue-non- specific isoenzyme) is a phosphoethanolamine and pyri- doxal-5'-phosphate ectophosphatase: normal and hypo- phosphatasia fibroblast study. American journal of human genetics. 1990;47(5):767-75. [PubMed]
30. Matsuo T, Fujiwara A, Nakamura K, Sadzuka Y. The ef- fects of vitamin B(6) compounds on cell proliferation and melanogenesis in B16F10 melanoma cells. Oncology letters. 2018;15(4):5181-4. [Crossref]  [PubMed]
31. Zhang P, Suidasari S, Hasegawa T, Yanaka N, Kato N. High concentrations of pyridoxal stimulate the expression of IG- FBP1 in HepG2 cells through upregulation of the ERK/c Jun pathway. Molecular medicine reports. 2013;8(4):973-8. [Crossref]  [PubMed]
32. Galluzzi L, Vacchelli E, Michels J, Garcia P, Kepp O, Se- novilla L, et al. Effects of vitamin B6 metabolism on onco- genesis, tumor progression and therapeutic responses. On- cogene. 2013;32(42):4995-5004. [Crossref]  [PubMed]
33. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascu- lar events after acute myocardial infarction. The New En- gland journal of medicine. 2006;354(15):1578-88. [Crossref]  [PubMed]
34. Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. Jama. 2008;300(7):795-804. [Crossref]  [PubMed]
35. Holowatyj AN, Ose J, Gigic B, Lin T, Ulvik A, Geijsen A, et al. Higher vitamin B6 status is associated with improved sur- vival among patients with stage I-III colorectal cancer. The American journal of clinical nutrition. 2022;116(2):303-13. [Crossref]  [PubMed]
36. Li C, He J, Fu H, Chang H. Association between Vitamin B(6) and Risk of Gastric Cancer: A Systematic Review and Meta-Analysis of Epidemiological Studies. Nutrition and cancer. 2023;75(10):1874-82. [Crossref]  [PubMed]
37. Mocellin S, Briarava M, Pilati P. Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis. Journal of the National Cancer Institute. 2017;109(3):1-9. [Crossref]  [PubMed]
38. Banikazemi Z, Haji HA, Mohammadi M, Taheripak G, Iran- ifar E, Poursadeghiyan M, et al. Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exo- somes. Journal of cellular biochemistry. 2018;119(1):185-96. [Crossref]  [PubMed]
39. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Advances in nutrition (Bethes- da, Md). 2012;3(1):21-38. [Crossref]  [PubMed]
40. Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer ep- idemiology. 2011;35(1):2-10. [Crossref]  [PubMed]
41. Nasir A, Bullo MMH, Ahmed Z, Imtiaz A, Yaqoob E, Ja- doon M, et al. Nutrigenomics: Epigenetics and cancer pre- vention: A comprehensive review. Critical reviews in food science and nutrition. 2020;60(8):1375-87. [Crossref]  [PubMed]
42. Mason JB. Unraveling the complex relationship be- tween folate and cancer risk. BioFactors (Oxford, En- gland). 2011;37(4):253-60. [Crossref]  [PubMed]
43. Carroll C, Cooper K, Papaioannou D, Hind D, Tappenden P, Pilgrim H, et al. Meta-analysis: folic acid in the chemopre- vention of colorectal adenomas and colorectal cancer. Ali- mentary pharmacology & therapeutics. 2010;31(7):708-18. [Crossref]  [PubMed]
44. Pufulete M, Abbadi RA, Arno M, Ewins M, Green C, As- tarloa EA, et al. The influence of folate supplementation on global gene expression in normal colonic mucosa of sub- jects with colorectal adenoma. Molecular nutrition & food research. 2013;57(4):709-20. [Crossref]  [PubMed]
45. Cravo ML, Pinto AG, Chaves P, Cruz JA, Lage P, Nobre Leitão C, et al. Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic ad- enomas: correlation with nutrient intake. Clinical nutrition (Edinburgh, Scotland). 1998;17(2):45-9. [Crossref]  [PubMed]
46. Carmel R. Efficacy and safety of fortification and supple- mentation with vitamin B12: biochemical and physiological effects. Food and nutrition bulletin. 2008;29(2):S177-87. [Crossref]  [PubMed]
47. Nielsen MJ, Rasmussen MR, Andersen CB, Nexø E, Moestrup SK. Vitamin B12 transport from food to the body's cells--a sophisticated, multistep pathway. Nature reviews Gastroenterology & hepatology. 2012;9(6):345-54. [Crossref]  [PubMed]
48. Friso S, Choi SW. Gene-nutrient interactions and DNA methylation. The Journal of nutrition. 2002;132(8 Sup- pl):2382s-7s. [Crossref]  [PubMed]
49. Lacombe V, Chabrun F, Lacout C, Ghali A, Capitain O, Patsouris A, et al. Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer. Scientific reports. 2021;11(1):13361. [Crossref]  [PubMed]
50. Van de Roovaart HJ, Stevens MM, Goodridge AE, Baden KR, Sibbitt BG, Delaney E, et al. Safety and efficacy of vitamin B in cancer treatments: A systematic review. Jour- nal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Prac- titioners. 2024;30(3):451-63. [Crossref]  [PubMed]
51. Arendt JF, Pedersen L, Nexo E, Sørensen HT. Elevated plasma vitamin B12 levels as a marker for cancer: a pop- ulation-based cohort study. Journal of the National Cancer Institute. 2013;105(23):1799-805. [Crossref]  [PubMed]
52. Sun NH, Huang XZ, Wang SB, Li Y, Wang LY, Wang HC, et al. A dose-response meta-analysis reveals an association be- tween vitamin B12 and colorectal cancer risk. Public health nutrition. 2016;19(8):1446-56. [Crossref]  [PubMed]
53. Miranti EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, Männistö S, Taylor PR, et al. Low vitamin B(12) increas- es risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer. Int J Cancer. 2017;141(6):1120-9. [Crossref]  [PubMed]
54. Gupta Y, Kohli DV, Jain SK. Vitamin B12-mediated trans- port: a potential tool for tumor targeting of antineoplastic drugs and imaging agents. Critical reviews in therapeutic drug carrier systems. 2008;25(4):347-79. [Crossref]  [PubMed]
55. Shekhany NSS, Salai JS. Can Cobalamin prevent Oxal- iplatin induced peripheral neuropathy? AMJ (Advanced Medical Journal). 2019;5(2):60-6. [Crossref]
56. Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, bi- ology and the treatment of cancer. Biochimica et biophysica acta. 2012;1826(2):443-57. [Crossref]  [PubMed]
57. Blaszczak W, Barczak W, Masternak J, Kopczyński P, Zhitkovich A, Rubiś B. Vitamin C as a Modulator of the Response to Cancer Therapy. Molecules (Basel, Swit- zerland). 2019;24(3).453. [Crossref]  [PubMed]
58. Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Sey- mour J, et al. Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer So- ciety cohort. Cancer epidemiology, biomarkers & preven- tion : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preven- tive Oncology. 2001;10(1):17-23. [PubMed]
59. Abdel-Latif MMM, Babar M, Kelleher D, Reynolds JV. A pilot study of the impact of Vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients. Journal of cancer research and therapeutics. 2019;15(1):185-91. [Crossref]  [PubMed]
60. Goyal H, Perisetti A, Rahman MR, Levin A, Lippi G. Vita- min D and Gastrointestinal Cancers: A Narrative Review. Digestive diseases and sciences. 2019;64(5):1098-109. [Crossref]  [PubMed]
61. Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, et al. Phase I evaluation of intravenous ascor- bic acid in combination with gemcitabine and erlo- tinib in patients with metastatic pancreatic cancer. PLoS One. 2012;7(1):29794. [Crossref]  [PubMed]
62. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitiv- ity of ovarian cancer and reduced toxicity of chemothera- py. Science translational medicine. 2014;6(222):222ra18. [Crossref]  [PubMed]
63. Vollbracht C, Schneider B, Leendert V, Weiss G, Auerbach L, Beuth J. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radio- therapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In vivo (Athens, Greece). 2011;25(6):983-90. [PubMed]
64. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Annals of internal medi- cine. 2004;140(7):533-537. [Crossref]  [PubMed]
65. Abdullah M, Jamil RT, Attia FN. Vitamin C (Ascorbic Acid). StatPearls [Internet]: Treasure Island (FL): StatPearls Publishing; 2024 Jan. [Link]
66. Dawsey SP, Hollenbeck A, Schatzkin A, Abnet CC. A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers. PLoS One. 2014;9(2):e88774. [Crossref]  [PubMed]
67. Jenab M, Riboli E, Ferrari P, Sabate J, Slimani N, Norat T, et al. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcino- genesis. 2006;27(11):2250-7. [PubMed]
68. Liu C, Russell RM. Nutrition and gastric cancer risk: an up- date. Nutrition reviews. 2008;66(5):237-49. [Crossref]  [PubMed]
69. Sizar O, Khare S, Goyal A, Givler A. Vitamin D Deficien- cy. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 17, 2023. [PubMed]
70. Fleet JC. Molecular actions of vitamin D contribut- ing to cancer prevention. Molecular aspects of medi- cine. 2008;29(6):388-96. [Crossref]  [PubMed]
71. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature reviews Cancer. 2007;7(9):684-700. [Crossref]  [PubMed]
72. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocrine re- views. 2012;33(3):456-92. [Crossref]  [PubMed]
73. Apperly FL. The relation of solar radiation to cancer mor- tality in North America. Cancer research. 1941;1(3):191-5. [PubMed]
74. Liu W, Zhang L, Xu HJ, Li Y, Hu CM, Yang JY, et al. The An- ti-Inflammatory Effects of Vitamin D in Tumorigenesis. In- ternational journal of molecular sciences. 2018;19(9).2736. [Crossref]  [PubMed]
75. Cross HS, Bises G, Lechner D, Manhardt T, Kállay E. The Vitamin D endocrine system of the gut-its possible role in colorectal cancer prevention. The Journal of steroid bio- chemistry and molecular biology. 2005;97(1-2):121-8. [Crossref]  [PubMed]
76. Trowbridge R, Kizer RT, Mittal SK, Agrawal DK. 1,25-di- hydroxyvitamin D in the pathogenesis of Barrett's esopha- gus and esophageal adenocarcinoma. Expert review of clin- ical immunology. 2013;9(6):517-33. [Crossref]  [PubMed]
77. Bao A, Li Y, Tong Y, Zheng H, Wu W, Wei C. Tumor-sup- pressive effects of 1, 25-dihydroxyvitamin D3 in gastric cancer cells. Hepato-gastroenterology. 2013;60(124):943-8. [PubMed]
78. Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ, et al. Prognostic effects of 25-hydroxyvitamin D levels in gas- tric cancer. Journal of translational medicine. 2012;10:16. [Crossref]  [PubMed]
79. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, An- genendt P, et al. Core signaling pathways in human pancre- atic cancers revealed by global genomic analyses. Science (NewYork, NY). 2008;321(5897):1801-6. [Crossref]  [PubMed]
80. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endo- crinology and metabolism. 2011;96(7):1911-30. [Crossref]  [PubMed]
81. Yin L, Ordóñez-Mena JM, Chen T, Schöttker B, Arndt V, Brenner H. Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Preventive med- icine. 2013;57(6):753-64. [Crossref]  [PubMed]
82. Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. The New England jour- nal of medicine. 2019;380(1):33-44. [PubMed]
83. Lopez-Caleya JF, Ortega-Valín L, Fernández-Villa T, Del- gado-Rodríguez M, Martín-Sánchez V, Molina AJ. The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies. Cancer causes & control : CCC. 2022;33(2):167-82. [Crossref]  [PubMed]
84. Xu Y, Qian M, Hong J, Ng DM, Yang T, Xu L, et al. The ef- fect of vitamin D on the occurrence and development of col- orectal cancer: a systematic review and meta-analysis. Inter- national journal of colorectal disease. 2021;36(7):1329-44. [Crossref]  [PubMed]
85. Sokol RJ. Vitamin E. Present Knowledge in Nutrition. Ziegler EE, Filer LJ, eds. 7th ed. Washington, DC:Interna- tional Life Sciences Institute-Nutrition Foundation;1996. [Link]
86. Ricciarelli R, Zingg JM, Azzi A. Vitamin E: protective role of a Janus molecule. FASEB journal : official publication of the Federation of American Societies for Experimental Bi- ology. 2001;15(13):2314-25. [Crossref]  [PubMed]
87. Nomura AM, Ziegler RG, Stemmermann GN, Chyou PH, Craft NE. Serum micronutrients and upper aerodigestive tract cancer. Cancer epidemiology, biomarkers & preven- tion : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preven- tive Oncology. 1997;6(6):407-12. [Link]
88. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: sup- plementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. Journal of the National Cancer Insti- tute. 1993;85(18):1483-92. [Crossref]  [PubMed]
89. Wang Z, Joshi AM, Ohnaka K, Morita M, Toyomura K, Kono S, et al. Dietary intakes of retinol, carotenes, vitamin C, and vitamin E and colorectal cancer risk: the Fukuoka col- orectal cancer study. Nutrition and cancer. 2012;64(6):798- 805. [Crossref]  [PubMed]
90. Kabat GC, Kim MY, Sarto GE, Shikany JM, Rohan TE. Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative. European journal of clinical nutrition. 2012;66(5):549-54. [Crossref]  [PubMed]
91. Luo H, Fang YJ, Lu MS, Pan ZZ, Huang J, Chen YM, et al. Dietary and serum vitamins A and E and colorectal cancer risk in Chinese population: a case-control study. European journal of cancer prevention : the official jour- nal of the European Cancer Prevention Organisation (ECP). 2019;28(4):268-77. [Crossref]  [PubMed]
92. Egnell M, Fassier P, Lécuyer L, Gonzalez R, Zelek L, Vas- son MP, et al. Antioxidant intake from diet and supplements and risk of digestive cancers in middle-aged adults: results from the prospective NutriNet-Santé cohort. The British journal of nutrition. 2017;118(7):541-9. [Crossref]  [PubMed]
93. Cui L, Li L, Tian Y, Xu F, Qiao T. Association between Dietary Vitamin E Intake and Esophageal Cancer Risk: An Updated Meta-Analysis. Nutrients. 2018;10(7). [Crossref]  [PubMed]
94. Jiang Q. Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy. Advances in nutrition (Bethesda, Md). 2017;8(6):850-67. [Crossref]  [PubMed]
95. McMillan DC, Sattar N, Talwar D, O'Reilly DS, McArd- le CS. Changes in micronutrient concentrations follow- ing anti-inflammatory treatment in patients with gas- trointestinal cancer. Nutrition (Burbank, Los Angeles County, Calif). 2000;16(6):425-8. [Crossref]  [PubMed]
96. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science (New York, NY). 1977;197(4299):165-7. [Crossref]  [PubMed]
97. Sung L, Greenberg ML, Koren G, Tomlinson GA, Tong A, Malkin D, et al. Vitamin E: the evidence for multiple roles in cancer. Nutrition and cancer. 2003;46(1):1-14. [Crossref]  [PubMed]
98. Vinceti M, Filippini T, Wise LA. Environmental Seleni- um and Human Health: an Update. Current environmental health reports. 2018;5(4):464-85. [Crossref]  [PubMed]
99. Razaghi A, Poorebrahim M, Sarhan D, Björnstedt M. Se- lenium stimulates the antitumour immunity: Insights to future research. European journal of cancer (Oxford, En- gland:1990). 2021;155:256-67. [Crossref]  [PubMed]
100. Selenius M, Rundlöf AK, Olm E, Fernandes AP, Björnst- edt M. Selenium and the selenoprotein thioredoxin reduc- tase in the prevention, treatment and diagnostics of cancer. Antioxidants & redox signaling. 2010;12(7):867-80. [Crossref]  [PubMed]
101. Hughes DJ, Fedirko V, Jenab M, Schomburg L, Méplan C, Freisling H, et al. Selenium status is associated with colorec- tal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int J Cancer. 2015;136(5):1149-61. [PubMed]
102. Lener MR, Scott RJ, Wiechowska-Kozłowska A, Serra- no-Fernández P, Baszuk P, Jaworska-Bieniek K, et al. Se- rum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer. Cancer research and treatment. 2016;48(3):1056-64. [Crossref]  [PubMed]
103. Gül-Klein S, Haxhiraj D, Seelig J, Kästner A, Hackler J, Sun Q, et al. Serum Selenium Status as a Diagnostic Mark- er for the Prognosis of Liver Transplantation. Nutrients. 2021;13(2). [Crossref]  [PubMed]
104. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunt- er EW, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. Journal of the National Cancer Institute. 2000;92(21):1753-63. [Crossref]  [PubMed]
105. Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenter- ology. 2010;138(5):1704-13. [Crossref]  [PubMed]
106. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, et al. Total and cancer mortality after supplemen- tation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. Journal of the National Cancer Institute. 2009;101(7):507-18. [Crossref]  [PubMed]
107. Retondario A, Souza AM, Fernandes R, Bricarello LP, Alves MA, Zeni L, et al. Usual intake and dietary sources of Sele- nium in adolescents: A cross-sectional school-based study. Clinical nutrition ESPEN. 2019;33:91-7. [Crossref]  [PubMed]
108. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Jr., Slate EH, Fischbach LA, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nu- tritional Prevention of Cancer Trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the Amer- ican Society of Preventive Oncology. 2002;11(7):630-9. [PubMed]
109. Skrajnowska D, Bobrowska-Korczak B. Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms. Nutrients. 2019;11(10). [Crossref]  [PubMed]
110. Zhang Q, Lenardo MJ, Baltimore D. 30 Years of NF-B: A Blossoming of Relevance to Human Pathobiology. Cell. 2017;168(1-2):37-57. [Crossref]  [PubMed]
111. Koren O, Tako E, editors. Chronic dietary zinc deficiency al- ters gut microbiota composition and function. Proceedings; 2020: MDPI. [Crossref]  [PubMed]
112. Ribeiro SM, Braga CB, Peria FM, Domenici FA, Martinez EZ, Feres O, et al. Effect of Zinc Supplementation on Anti- oxidant Defenses and Oxidative Stress Markers in Patients Undergoing Chemotherapy for Colorectal Cancer: a Place- bo-Controlled, Prospective Randomized Trial. Biological trace element research. 2016;169(1):8-16. [Crossref]  [PubMed]
113. Ribeiro SMF, Braga CBM, Peria FM, Martinez EZ, Rocha J, Cunha SFC. Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer. Ein-stein (Sao Paulo, Brazil). 2017;15(1):24-8. [Crossref]  [PubMed]
114. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase mul- tigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free radical biology & med- icine. 2002;33(3):337-49. [Crossref]  [PubMed]
115. Stepien M, Jenab M, Freisling H, Becker NP, Czuban M, Tjønneland A, et al. Pre-diagnostic copper and zinc bio- markers and colorectal cancer risk in the European Pro- spective Investigation into Cancer and Nutrition cohort. Carcinogenesis. 2017;38(7):699-707. [Crossref]  [PubMed]
116. Fang AP, Chen PY, Wang XY, Liu ZY, Zhang DM, Luo Y, et al. Serum copper and zinc levels at diagnosis and hepa- tocellular carcinoma survival in the Guangdong Liver Can- cer Cohort. Int J Cancer. 2019;144(11):2823-32. [Crossref]  [PubMed]
117. Jacobs ET, Jurutka PW, Martínez ME, Alberts DS. Vita- min D, calcium, and colorectal neoplasia: new insights on mechanisms of action. Cancer prevention research (Phila- delphia, Pa). 2009;2(3):197-9. [Crossref]  [PubMed]
118. Yang K, Lamprecht SA, Shinozaki H, Fan K, Yang W, New- mark HL, et al. Dietary calcium and cholecalciferol modu- late cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. The Journal of nutrition. 2008;138(9):1658-63. [Crossref]  [PubMed]
119. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. Journal of the National Cancer Institute. 2004;96(13):1015-22. [Crossref]  [PubMed]
120. Heine-Bröring RC, Winkels RM, Renkema JM, Kragt L, van Orten-Luiten AC, Tigchelaar EF, et al. Dietary supple- ment use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies. Int J Can- cer. 2015;136(10):2388-401. [Crossref]  [PubMed]
121. Mulholland HG, Murray LJ, Anderson LA, Cantwell MM. Vitamin D, calcium and dairy intake, and risk of oesoph- ageal adenocarcinoma and its precursor conditions. The British journal of nutrition. 2011;106(5):732-41. [Crossref]  [PubMed]
122. Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jun-gner I, Walldius G, et al. Serum calcium and risk of gas- trointestinal cancer in the Swedish AMORIS study. BMC public health. 2013;13:663. [Crossref]  [PubMed]  [PMC]
123. Phipps O, Al-Hassi HO, Quraishi MN, Kumar A, Brookes MJ. Influence of Iron on the Gut Microbiota in Colorectal Cancer. Nutrients. 2020;12(9).2512. [Crossref]  [PubMed]  [PMC]
124. Xue X, Shah YM. Intestinal iron homeostasis and colon tu- morigenesis. Nutrients. 2013;5(7):2333-51. [Crossref]  [PubMed]  [PMC]
125. Phipps O, Brookes MJ, Al-Hassi HO. Iron deficien- cy, immunology, and colorectal cancer. Nutrition re- views. 2021;79(1):88-97. [Crossref]  [PubMed]
126. Paganoni R, Lechel A, Vujic Spasic M. Iron at the Inter- face of Hepatocellular Carcinoma. International journal of molecular sciences. 2021;22(8).4097. [Crossref]  [PubMed]  [PMC]
127. Keeler BD, Simpson JA, Ng O, Padmanabhan H, Brookes MJ, Acheson AG. Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorec- tal cancer. The British journal of surgery. 2017;104(3):214-21. [PubMed]
128. Marques O, da Silva BM, Porto G, Lopes C. Iron homeo- stasis in breast cancer. Cancer letters. 2014;347(1):1-14. [Crossref]  [PubMed]
129. Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, et al. Iron metabolism and iron sup- plementation in cancer patients. Wiener klinische Wochen- schrift. 2015;127(23-24):907-19. [Crossref]  [PubMed]  [PMC]
130. O'Rorke MA, Cantwell MM, Abnet CC, Brockman AJ, Murray LJ. Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. Int J Cancer. 2012;131(8):1882-91. [Crossref]  [PubMed]  [PMC]
131. Sawayama H, Iwatsuki M, Kuroda D, Toihata T, Uchihara T, Koga Y, et al. Total iron-binding capacity is a novel prog- nostic marker after curative gastrectomy for gastric cancer. International journal of clinical oncology. 2018;23(4):671-80. [Crossref]  [PubMed]
132. Lee DH, Jacobs DR, Jr., Folsom AR. A hypothesis: inter- action between supplemental iron intake and fermenta- tion affecting the risk of colon cancer. The Iowa Women's Health Study. Nutrition and cancer. 2004;48(1):1-5. [Crossref]  [PubMed]